MedTrace Logo

Application of Percutaneous Electrolysis, Percutaneous Neuromodulation and Eccentric Exercise

NCT03184181 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2023-05-10

No results posted yet for this study

Summary

The supraspinatus muscle tendinopathy show a big impact, however, there is a lack of awareness about the options of the physiotherapist treatment. It is necessary to do studies about effectiveness of therapeutic percutaneous electrolysis (EPTE®). This technique enables treatment of the tendinopathies and the broken muscle fibrilare. It is base on the application of galvanic current through a acupuncture needle. To analyze the effectiveness of therapeutic percutaneous electrolysis (EPTE®) in the treatment of supraspinatus muscle tendinopathy. Single center randomized controlled trial, parallel treatment design. A specialist physician will be diagnosed the supraspinatus muscle tendinopathy. Participants will be randomly assigned to receive treatmen for 4 weeks: EPTE® associated with eccentric exercises or dry needling with the same eccentric exercises. Both interventions were performed under ultrasound guidance with a portable ultrasound (General Electric LogicE). Data will be collected by a blinded evaluator.

Conditions

  • Supraspinatus Tendinitis

Interventions

OTHER

EPTE® group

Therapeutic Percutaneous Electrolysis once week for four weeks associated with eccentric exercises devices at home.

OTHER

Dry needling group

The intervention for this group consisted of dry needling in trigger points associated with eccentric exercises devices at home.

Sponsors & Collaborators

  • Jorge Manuel Góngora Rodriguez

    collaborator UNKNOWN

  • Manuel Rodriguez Huguet

    collaborator UNKNOWN

  • Pablo Rodriguez Huguet

    collaborator UNKNOWN

  • Rocío Martín Valero

    collaborator UNKNOWN

  • University of Cadiz

    lead OTHER

Principal Investigators

  • Manuel Manuel, BSc · University of Cadiz

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2018-01-01
Completion
2018-02-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03184181 on ClinicalTrials.gov